AGYTF fundamentals
An in-depth look to Allergy Therapeutics Plc. operating, investing, and financing activities
AGYTF free cash flow for H1 24 is -18.1 M USD. For 2023, AGYTF free cash flow was -45.17 M USD and operating cash flow was -39.24 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM